Skip to main contentSkip to footer
T

Trialytics

Find trialsHow it worksAboutFAQBlog
Home/Conditions/Carcinoma In Situ/Oregon

Carcinoma In Situ clinical trials in Oregon

3 active Carcinoma In Situ trials with a site in Oregon. Describe your situation to see which ones look like a fit.

  • LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïveRECRUITINGPhase 1/Phase 2NCT04752722
  • A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)RECRUITINGPhase 2NCT06833073
  • Project: Every Child for Younger Patients With CancerRECRUITINGNCT02402244

Guides for people searching for a trial

  • How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
  • Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
  • How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
  • What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
  • 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
  • You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.

← All Carcinoma In Situ trials

T

Trialytics

Clinical trials explained in plain language.

Product

  • How it Works
  • Search Trials
  • Browse by Condition
  • Browse by Biomarker

Company

  • About
  • Blog
  • Contact

Legal

  • Privacy Policy
  • Terms of Use
  • HIPAA Authorization
  • Request HIPAA Compliance Statement

© 2026 Trialytics. All rights reserved.